On the matter of Paxlovid not having been approved yet, I’m considering writing to the CDER Ombudsman:
https://www.fda.gov/about-fda/cder-contact-information/cder-ombudsman
And cc’ing my elective reps. As a hedge, and so as not to be accused of foul play if I decide to jump into any of the prediction markets, I might bet against my preferred outcome (rapid approval)
On the matter of Paxlovid not having been approved yet, I’m considering writing to the CDER Ombudsman:
https://www.fda.gov/about-fda/cder-contact-information/cder-ombudsman
And cc’ing my elective reps. As a hedge, and so as not to be accused of foul play if I decide to jump into any of the prediction markets, I might bet against my preferred outcome (rapid approval)